These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33676834)

  • 1. The Use of 5-Alpha Reductase Inhibitors and Alpha-1 Blockers Does Not Improve Clinical Outcome in Male Patients Undergoing Radical Cystectomy for Bladder Cancer in Quebec, Canada.
    Wissing MD; O'Flaherty A; Dragomir A; Tanguay S; Kassouf W; Aprikian AG
    Clin Genitourin Cancer; 2021 Aug; 19(4):371-371.e9. PubMed ID: 33676834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada.
    Wissing MD; O'Flaherty A; Dragomir A; Tanguay S; Kassouf W; Aprikian AG
    BMC Urol; 2023 Jul; 23(1):119. PubMed ID: 37452329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000-2015.
    Wissing MD; Santos F; Zakaria AS; O'Flaherty A; Tanguay S; Kassouf W; Aprikian AG
    J Surg Oncol; 2019 Jun; 119(8):1135-1144. PubMed ID: 30919984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 5α-Reductase Inhibitor Prescription With Bladder Cancer Progression in Males in South Korea.
    An MH; Kim MS; Kim C; Noh TI; Joo KJ; Lee DH; Yi KH; Kwak JW; Hwang TH; Park RW; Kang SH
    JAMA Netw Open; 2023 May; 6(5):e2313667. PubMed ID: 37191958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors.
    Mäkelä VJ; Kotsar A; Tammela TLJ; Murtola TJ
    J Urol; 2018 Oct; 200(4):743-748. PubMed ID: 29730200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study.
    Santos F; Dragomir A; Kassouf W; Franco EL; Aprikian A
    BJU Int; 2015 Mar; 115(3):389-96. PubMed ID: 24656061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.
    Santos F; Zakaria AS; Kassouf W; Tanguay S; Aprikian A
    World J Urol; 2015 Sep; 33(9):1323-30. PubMed ID: 25471670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.
    Santos F; Dragomir A; Zakaria AS; Kassouf W; Aprikian A
    J Surg Oncol; 2016 Feb; 113(2):223-8. PubMed ID: 26696270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study.
    Wahafu W; Liu S; Xu W; Wang M; He Q; Song L; Wang M; Yang F; Hua L; Niu Y; Xing N
    BMC Urol; 2019 Nov; 19(1):117. PubMed ID: 31733646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec, Canada, 2000-2016.
    Wissing MD; Kassouf W; Tanguay S; Aprikian AG
    Can Urol Assoc J; 2020 May; 14(5):E191-E201. PubMed ID: 31793860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Yao Z; Jiang Y; Zhu X; Wu B; Bai S
    Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder.
    Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A
    Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
    Koie T; Ohyama C; Yamamoto H; Hatakeyama S; Imai A; Yoneyama T; Hashimoto Y; Kitayam M; Hirota K
    Urol Oncol; 2014 Aug; 32(6):820-5. PubMed ID: 24951323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis.
    Murthy PB; Lone Z; Corrigan D; Campbell R; Munoz-Lopez C; Caveney M; Gerber D; Ericson KJ; Thomas L; Zhang JH; Kaouk J; Weight C; Berglund R; Haber GP; Lee BH
    Urol Oncol; 2022 Jan; 40(1):10.e13-10.e19. PubMed ID: 34400070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial Carcinoma in Bladder Diverticula: A Multicenter Analysis of Characteristics and Clinical Outcomes.
    Voskuilen CS; Seiler R; Rink M; Poyet C; Noon AP; Roghmann F; Necchi A; Aziz A; Lavollé A; Young MJ; Marks P; Saba K; van Rhijn BWG; Fransen van de Putte EE; Ablat J; Black PC; Sosnowski R; Dobruch J; Kumar P; Jallad S; Catto JWF; Xylinas E; Hendricksen K;
    Eur Urol Focus; 2020 Nov; 6(6):1226-1232. PubMed ID: 30559065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes following Radical Cystectomy: Systematic Review and Meta-Analysis.
    Cacciamani GE; Ghodoussipour S; Mari A; Gill KS; Desai M; Artibani W; Gill PS; Shariat SF; Gill IS; Djaladat H
    J Urol; 2020 Oct; 204(4):649-660. PubMed ID: 32105187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.